Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion

The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1

(2015) Astrid Plamboeck et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test

(2015) A. Y. H. Lee et al.   CLINICAL CHEMISTRY

Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide

(2015) Rune Ehrenreich Kuhre et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Islet α cells and glucagon—critical regulators of energy homeostasis

(2015) Jonathan E. Campbell et al.   Nature Reviews Endocrinology

Stability of glucagon-like peptide 1 and glucagon in human plasma

(2015) N. J. Wewer Albrechtsen et al.   Endocrine Connections

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

(2014) Nicolai J. Wewer Albrechtsen et al.   DIABETOLOGIA

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

(2014) Monika J Bak et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Development of a high-throughput UHPLC–MS/MS (SRM) method for the quantitation of endogenous glucagon from human plasma

(2014) James W Howard et al.   Bioanalysis

Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes

(2013) Philip E. Cryer   NEW ENGLAND JOURNAL OF MEDICINE